These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study. Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544 [TBL] [Abstract][Full Text] [Related]
3. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine. Kuhlman JJ; Lalani S; Magluilo J; Levine B; Darwin WD J Anal Toxicol; 1996 Oct; 20(6):369-78. PubMed ID: 8889672 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the pharmacokinetics of buprenorphine and norbuprenorphine in rats after intravenous bolus administration of buprenorphine. Gopal S; Tzeng TB; Cowan A Eur J Pharm Sci; 2002 Apr; 15(3):287-93. PubMed ID: 11923061 [TBL] [Abstract][Full Text] [Related]
5. Intravenous and sublingual buprenorphine in horses: pharmacokinetics and influence of sampling site. Messenger KM; Davis JL; LaFevers DH; Barlow BM; Posner LP Vet Anaesth Analg; 2011 Jul; 38(4):374-84. PubMed ID: 21501371 [TBL] [Abstract][Full Text] [Related]
6. High-sensitivity analysis of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in plasma and urine by liquid chromatography-mass spectrometry. Regina KJ; Kharasch ED J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():23-31. PubMed ID: 24095872 [TBL] [Abstract][Full Text] [Related]
7. Estimated dose exposure of the neonate to buprenorphine and its metabolite norbuprenorphine via breastmilk during maternal buprenorphine substitution treatment. Ilett KF; Hackett LP; Gower S; Doherty DA; Hamilton D; Bartu AE Breastfeed Med; 2012 Aug; 7():269-74. PubMed ID: 22011128 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic-pharmacodynamic modelling of intravenous buprenorphine in conscious horses. Love EJ; Pelligand L; Taylor PM; Murrell JC; Sear JW Vet Anaesth Analg; 2015 Jan; 42(1):17-29. PubMed ID: 24735059 [TBL] [Abstract][Full Text] [Related]
9. Salivary Therapeutic Monitoring of Buprenorphine in Neonates After Maternal Sublingual Dosing Guided by Physiologically Based Pharmacokinetic Modeling. Alsmadi MM Ther Drug Monit; 2024 Aug; 46(4):512-521. PubMed ID: 38366333 [TBL] [Abstract][Full Text] [Related]
10. Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women. Concheiro M; Jones HE; Johnson RE; Choo R; Huestis MA Ther Drug Monit; 2011 Oct; 33(5):619-26. PubMed ID: 21860340 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Pharmacokinetics of Single- and Multiple-dose Buprenorphine Buccal Film in Healthy Volunteers. Bai SA; Xiang Q; Finn A Clin Ther; 2016 Feb; 38(2):358-69. PubMed ID: 26804639 [TBL] [Abstract][Full Text] [Related]
12. Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine. Kuhlman JJ; Levine B; Johnson RE; Fudala PJ; Cone EJ Addiction; 1998 Apr; 93(4):549-59. PubMed ID: 9684393 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality. Harris DS; Mendelson JE; Lin ET; Upton RA; Jones RT Clin Pharmacokinet; 2004; 43(5):329-40. PubMed ID: 15080765 [TBL] [Abstract][Full Text] [Related]
14. Buprenorphine exposure in infants of opioid-dependent mothers at birth. Bartu AE; Ilett KF; Hackett LP; Doherty DA; Hamilton D Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):342-7. PubMed ID: 22428721 [TBL] [Abstract][Full Text] [Related]
15. A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies. Moody DE; Slawson MH; Strain EC; Laycock JD; Spanbauer AC; Foltz RL Anal Biochem; 2002 Jul; 306(1):31-9. PubMed ID: 12069411 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of buprenorphine after intravenous administration in the mouse. Yu S; Zhang X; Sun Y; Peng Y; Johnson J; Mandrell T; Shukla AJ; Laizure SC J Am Assoc Lab Anim Sci; 2006 May; 45(3):12-6. PubMed ID: 16642964 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of Sublingual Buprenorphine Tablets Following Single and Multiple Doses in Chinese Participants With and Without Opioid Use Disorder. Dong R; Wang H; Li D; Lang L; Gray F; Liu Y; Laffont CM; Young M; Jiang J; Liu Z; Learned SM Drugs R D; 2019 Sep; 19(3):255-265. PubMed ID: 31197606 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of buprenorphine in pregnant sheep after intravenous injection. Hakomäki H; Kokki H; Lehtonen M; Ranta VP; Räsänen J; Voipio HM; Kokki M Pharmacol Res Perspect; 2021 Apr; 9(2):e00726. PubMed ID: 33619904 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and analgesic effects of intravenous, intramuscular or subcutaneous buprenorphine in dogs undergoing ovariohysterectomy: a randomized, prospective, masked, clinical trial. Steagall PV; Ruel HLM; Yasuda T; Monteiro BP; Watanabe R; Evangelista MC; Beaudry F BMC Vet Res; 2020 May; 16(1):154. PubMed ID: 32448336 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of buprenorphine, norbuprenorphine and naloxone in human plasma by liquid chromatography/tandem mass spectrometry. Liu Y; Li X; Xu A; Nasser AF; Heidbreder C J Pharm Biomed Anal; 2016 Feb; 120():142-52. PubMed ID: 26730511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]